Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

All relapsing multiple sclerosis patients should be managed at a specialist clinic - YES.
Papers: 31 Jul 2014 - 7 Aug 2014
Static posturography across the EDSS scale in people with multiple sclerosis: a cross sectional study.
Systematic Review and Critique of Health Economic Models on Relapsing-Remitting Multiple Sclerosis in the UK.
Cost-Effectiveness of Subcutaneous Interferon Beta-1A in a Sub-Population of Multiple Sclerosis Patients (Kurtzke Expanded Disability Status Scale [EDSS]: >3.5-5.0).
MS Research Roundup: September 29, 2014
The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.
A fatal mycotic sepsis after retrograde intrarenal surgery: a case report and literature review.
Using a Panel Survey to Identify Predictors of Disease-Modifying Drug Adherence in Patients with Multiple Sclerosis.
ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity.
Comparison of a Markov Cohort Model and a Discrete-Event Simulation for Economic Analyses of Treatments for Multiple Sclerosis.
Working Ability and Monetarily Valued Productivity of Patients with Multiple Sclerosis Treated with Natalizumab.
A surface-based technique for mapping homotopic interhemispheric connectivity: Development, characterization, and clinical application.
The Cost Burden of Switching Patients with Relapsing-Remitting Multiple Sclerosis from Glatiramer Acetate To Newly-Approved Disease Modifying Therapies.
Optic neuritis as a presenting symptom of Mycoplasma pneumoniae infection.
Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study.
Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study.
Tbet or Continued RORγt Expression Is Not Required for Th17-Associated Immunopathology.
Cost-Utility Analysis (cua) Of First-Line Disease-Modifying Treatments (DMT) Versus Best Supportive Care (Bsc) In Finnish Relapsing-Remitting Multiple Sclerosis (RRMS) Patients.
Icariin exerts estrogen-like activity in ameliorating EAE via mediating estrogen receptor β, modulating HPA function and glucocorticoid receptor expression.
Papers: 24 Jul 2015 - 31 Jul 2015
Switching from natalizumab to fingolimod: an observational study.
Boosting CNS axon regeneration by circumventing limitations of natural cytokine signaling.
Evaluation of Methods for the Inclusion of Real World Evidence in Network Meta-Analysis - A Case Study in Multiple Sclerosis.
The association of IL-18 gene promoter polymorphisms and the levels of serum IL-18 on the risk of multiple sclerosis.

Pages